Table 1 Patients demographics and clinical data

Patients

n = 38

n = 20

n = 46

n = 30

Gender

f = 20; m = 18

f = 12; m = 8

f = 23; m = 23

f = 10; m = 20

Age

68 ± 9.0

70 ± 9.2

68 ± 9.4

69 ± 8.4

Piritramide

OP: n = 14 (36.8%): 10.7 mg ± 5.8

OP: n = 2 (10%): 8.3 mg ± 1.1

OP: n = 29 (63.0%): 8.1 mg ± 4.5

OP: n = 3 (10.0%): 7.5 mg ± 0.0

Day 1: n = 4 (10.5%): 9.4 mg ± 3.8

Day 1: -

Day 1: n = 2 (4.4%): 7.5 mg ± 0.0

Day 1: n = 4 (13.3%): 9.4 mg ± 3.8

Day 2: n = 3 (7.9%): 7.5 mg ± 0.0

Day 2: -

Day 2: -

Day 2: -

Implant fixation

cementless: n = 20 (52.6%)

cementless: n = 11 (55.0%)

cementless: n = 23 (50.0%)

cementless: n = 16 (53.3%)

hybrid n = 10 (26.3%)

hybrid n = 5 (25.0%)

hybrid n = 9 (19.6%)

hybrid n = 5 (16.7%)

cemented n = 8 (21.1%)

cemented n = 4 (20.0%)

cemented n = 14 (30.4%)

cemented n = 9 (30.0%)

Salvage pain management

n = 1 (2.6%)

n = 1 (2.6%)

n = 1 (2.6%)

–

→PCIA: n = 1

→PCIA: n = 1

→3in1: n = 1

→G.A.: n = 1

→3in1: n = 3

→PCIA: n = 1

LIA

–

–

100 ml

100 ml

Dexamethasone

–

–

15.4 mg ± 3.1

16.6 mg ± 2.1